MANAGEMENT OF PNEUMONIA WITH MULTILOCULATED LEFT PLEURAL EFFUSION CAUSED BY EXTENDED SPECTRUM BETA-LACTAMASES PRODUCING KLEBSIELLA PNEUMONIAE

Simple item page
dc.creatorGoyal, Suresh
dc.date.accessioned2026-01-10T18:52:32Z
dc.date.available2026-01-10T18:52:32Z
dc.date.issued2015-10-28
dc.descriptionIncrease in the mortality and morbidity in pleural infection is a concern worldwide due to increasing resistant Gram negative pathogens like Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella species. Rise of pneumonia due to K. pneumoniae, is more likely observed in alcoholics, diabetics, hospitalized and patients receiving mechanical ventilation. In the present study, we discuss a case of a 59 year old male patient with pulmonary effusion infected with extended spectrum beta-lactamases (ESBL) producing K. pneumoniae with co-morbidities of uncontrolled Type II diabetes mellitus (DM), hypertension and coronary artery disease (CAD), treated with a newer antibiotic adjuvant entity: Elores (ceftriaxone/sulbactam/disodium edetate) and recovered well. KEYWORDS: Gram negative pathogens; Beta-lactamases; Elores.en-US
dc.formatapplication/pdf
dc.identifierhttps://sumathipublications.com/index.php/ijcbr/article/view/98
dc.identifier.urihttps://repos.sumathipublications.com:8000/handle/123456789/95
dc.languageeng
dc.publisherSumathi Publicationsen-US
dc.relationhttps://sumathipublications.com/index.php/ijcbr/article/view/98/125
dc.relation.ispartofInternational Journal of Clinical and Biomedical Researchen-US
dc.relation.ispartofseriesVolume 1, Issue 4en-US
dc.rightsCopyright (c) 2015 Suresh Goyalen-US
dc.sourceInternational Journal of Clinical and Biomedical Research; Volume 1, Issue 4; October 2015; 73-76en-US
dc.source2395-0471
dc.source2521-0394
dc.titleMANAGEMENT OF PNEUMONIA WITH MULTILOCULATED LEFT PLEURAL EFFUSION CAUSED BY EXTENDED SPECTRUM BETA-LACTAMASES PRODUCING KLEBSIELLA PNEUMONIAEen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Files

Collections

International Journal of Clinical and Biomedical Research (IJCBR)